Conference Coverage

Denosumab's benefits persist through 8 years

Publish date: July 2, 2014

 

AT ICE/ENDO 2014

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Chronic vulvar irritation, itching, and pain. What is the diagnosis?
MDedge ObGyn
Chronic vulvar symptoms and dermatologic disruptions: How to make the correct diagnosis
MDedge ObGyn
Ospemifene found to have minimal effects on the endometrium at 52 weeks
MDedge ObGyn
Women’s Health Initiative study netted $37 billion in savings
MDedge ObGyn
Yearly monitoring does not predict fractures after bisphosphonate cessation
MDedge ObGyn
Hemorrhagic ovarian cysts: One entity with many appearances
MDedge ObGyn
What is the clinical and economic return on taxpayers’ $260M investment in the WHI?
MDedge ObGyn
Paroxetine mesylate 7.5 mg found to be a safe alternative to hormone therapy for menopausal women with hot flashes
MDedge ObGyn
Hormone therapy for menopausal vasomotor symptoms
MDedge ObGyn
Enigmatic inconsistencies between WHI data and conclusions; Exaggerated or intentionally fabricated data?
MDedge ObGyn